MCR 314 Pill: gray, four-sided, 17mm
The pill with imprint MCR 314 (Gray, Four-sided, 17mm) has been identified as Lamivudine 300 mg and is used for Hepatitis B, Nonoccupational Exposure, Occupational Exposure, and HIV Infection. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for MCR 314
Lamivudine
- Imprint
- MCR 314
- Strength
- 300 mg
- Color
- Gray
- Size
- 17.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Appco Pharma LLC
- National Drug Code (NDC)
- 55801-0314
- Inactive Ingredients
-
ferric oxide red,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about lamivudine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.